-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Protalix BioTherapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2011 to 2023.
- Protalix BioTherapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was -45.2 %, a 123% decline year-over-year.
- Protalix BioTherapeutics, Inc. annual Return On Equity for 2023 was 29.7 %, a 80.3% decline from 2022.
- Protalix BioTherapeutics, Inc. annual Return On Equity for 2022 was 151 %.
- Protalix BioTherapeutics, Inc. annual Return On Equity for 2021 was -881 %, a 4355% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)